Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl ...

Metformin, a medication to treat type 2 diabetes, is facing a recall over concerns it has been contaminated with a possible cancer-causing substance. Nostrum Laboratories Inc., the maker of Metformin, ...

One of the manufacturers of a Type 2 diabetes drug, Metformin Hydrochloride Extended-Release Tablets, extended its recall of its 500mg and 750 mg pills, the U.S. Food and Drug Administration reported ...

Nostrum Laboratories has voluntarily recalled another lot of metformin HCl extended-release tablets 750 mg dosage, expanding their initial announcement in November 2020. According to the new notice, ...

(CNN) — Two lots of a widely used type 2 diabetes medication, metformin, are being recalled due to possible contamination with a potentially cancer-causing compound. Metformin is designed to lower ...

Three makers of Type 2 diabetes drug Metformin announced recalls Friday, the U.S. Food & Drug Administration reported. The reason for the voluntary recalls: the U.S. Food & Drug Administration ...

Nostrum Laboratories is recalling Metformin HCl Extended Release Tablets because of NDMA above the acceptable daily intake limit. Nostrum Laboratories (Kansas City, MO) announced on Nov. 2, 2020 that ...

The company is voluntarily recalling all lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, because of the detection of N-Nitrosodimethylamine. Amneal Pharmaceuticals ...

Marksans Pharma Limited of India has expanded a recall it issued in June for Metformin Hydrochloride Extended Release tablets prescribed for people with Type 2 diabetes. The recall includes an ...

(Gray News) - The U.S. Food and Drug Administration announced Nostrum Laboratories, Inc. had expanded its voluntary recall of some of its Metformin HCl tablets. One lot of the Metformin HCl Extended ...